Susquehanna International Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $93.7M | Buy |
431,015
+145,084
| +51% | +$32.2M | 0.01% | 873 |
|
|
2025
Q4 | $65.3M | Sell |
285,931
-7,497
| -3% | -$1.71M | 0.01% | 1161 |
|
|
2025
Q3 | $67.9M | Sell |
293,428
-88,450
| -23% | -$18M | 0.01% | 1134 |
|
|
2025
Q2 | $70.9M | Buy |
381,878
+195,759
| +105% | +$36.4M | 0.01% | 946 |
|
|
2025
Q1 | $39M | Sell |
186,119
-606,602
| -77% | -$118M | 0.01% | 1183 |
|
|
2024
Q4 | $141M | Buy |
792,721
+467,534
| +144% | +$86M | 0.02% | 564 |
|
|
2024
Q3 | $64.2M | Sell |
325,187
-127,708
| -28% | -$23.8M | 0.01% | 909 |
|
|
2024
Q2 | $77.7M | Sell |
452,895
-106,898
| -19% | -$17.7M | 0.01% | 712 |
|
|
2024
Q1 | $102M | Sell |
559,793
-365,713
| -40% | -$63M | 0.02% | 659 |
|
|
2023
Q4 | $143M | Buy |
925,506
+131,656
| +17% | +$19.2M | 0.03% | 529 |
|
|
2023
Q3 | $118M | Sell |
793,850
-79,524
| -9% | -$11.7M | 0.02% | 542 |
|
|
2023
Q2 | $118M | Sell |
873,374
-404,255
| -32% | -$59.3M | 0.02% | 540 |
|
|
2023
Q1 | $204M | Buy |
1,277,629
+534,056
| +72% | +$81.6M | 0.04% | 347 |
|
|
2022
Q4 | $120M | Buy |
743,573
+571,001
| +331% | +$87.6M | 0.03% | 486 |
|
|
2022
Q3 | $23.2M | Sell |
172,572
-141,362
| -45% | -$20.3M | 0.01% | 1301 |
|
|
2022
Q2 | $48.1M | Sell |
313,934
-134,223
| -30% | -$20.5M | 0.01% | 878 |
|
|
2022
Q1 | $72.7M | Sell |
448,157
-2,128,255
| -83% | -$309M | 0.01% | 812 |
|
|
2021
Q4 | $349M | Buy |
2,576,412
+936,111
| +57% | +$111M | 0.05% | 304 |
|
|
2021
Q3 | $177M | Buy |
1,640,301
+370,430
| +29% | +$42.3M | 0.02% | 564 |
|
|
2021
Q2 | $143M | Buy |
1,269,871
+181,900
| +17% | +$20.5M | 0.02% | 641 |
|
|
2021
Q1 | $118M | Buy |
1,087,971
+248,432
| +30% | +$26.6M | 0.02% | 655 |
|
|
2020
Q4 | $90M | Sell |
839,539
-1,523,027
| -64% | -$146M | 0.01% | 703 |
|
|
2020
Q3 | $207M | Buy |
2,362,566
+701,718
| +42% | +$66.1M | 0.04% | 331 |
|
|
2020
Q2 | $163M | Sell |
1,660,848
-283,686
| -15% | -$25M | 0.04% | 354 |
|
|
2020
Q1 | $148M | Sell |
1,944,534
-38,566
| -2% | -$3.28M | 0.05% | 288 |
|
|
2019
Q4 | $176M | Buy |
1,983,100
+215,476
| +12% | +$17.9M | 0.05% | 311 |
|
|
2019
Q3 | $134M | Sell |
1,767,624
-611,709
| -26% | -$41.9M | 0.04% | 353 |
|
|
2019
Q2 | $173M | Buy |
2,379,333
+1,904,143
| +401% | +$150M | 0.06% | 257 |
|
|
2019
Q1 | $38.3M | Buy |
+475,190
| New | +$38.9M | 0.02% | 770 |
|
|
2018
Q4 | – | Sell |
-132,634
| Closed | -$11.7M | – | 8825 |
|
|
2018
Q3 | $12.5M | Sell |
132,634
-185,545
| -58% | -$17.6M | ﹤0.01% | 1726 |
|
|
2018
Q2 | $29.5M | Buy |
318,179
+156,683
| +97% | +$15.3M | 0.01% | 1006 |
|
|
2018
Q1 | $15.3M | Buy |
161,496
+115,896
| +254% | +$12.7M | 0.01% | 1431 |
|
|
2017
Q4 | $4.41M | Sell |
45,600
-176,896
| -80% | -$16.7M | ﹤0.01% | 2684 |
|
|
2017
Q3 | $19.8M | Buy |
222,496
+210,097
| +1,694% | +$16M | 0.01% | 1235 |
|
|
2017
Q2 | $899K | Sell |
12,399
-24,761
| -67% | -$1.66M | ﹤0.01% | 5483 |
|
|
2017
Q1 | $2.42M | Buy |
37,160
+6,960
| +23% | +$438K | ﹤0.01% | 3381 |
|
|
2016
Q4 | $1.89M | Buy |
+30,200
| New | +$1.84M | ﹤0.01% | 4187 |
|
|
2016
Q2 | – | Sell |
-941,532
| Closed | -$57.4M | – | 8457 |
|
|
2016
Q1 | $53.8M | Sell |
941,532
-294,277
| -24% | -$16.4M | 0.03% | 498 |
|
|
2015
Q4 | $73.2M | Sell |
1,235,809
-789,181
| -39% | -$45.5M | 0.03% | 461 |
|
|
2015
Q3 | $110M | Buy |
2,024,990
+1,422,019
| +236% | +$92.6M | 0.05% | 350 |
|
|
2015
Q2 | $40.5M | Sell |
602,971
-871,013
| -59% | -$56.9M | 0.02% | 806 |
|
|
2015
Q1 | $86.3M | Buy |
1,473,984
+826,328
| +128% | +$49.9M | 0.04% | 416 |
|
|
2014
Q4 | $42.4M | Sell |
647,656
-89,124
| -12% | -$5.62M | 0.02% | 819 |
|
|
2014
Q3 | $42.6M | Buy |
736,780
+585,430
| +387% | +$32.5M | 0.02% | 838 |
|
|
2014
Q2 | $8.54M | Buy |
151,350
+4,577
| +3% | +$240K | ﹤0.01% | 2302 |
|
|
2014
Q1 | $7.54M | Sell |
146,773
-173,539
| -54% | -$8.77M | ﹤0.01% | 2346 |
|
|
2013
Q4 | $16.9M | Buy |
320,312
+127,383
| +66% | +$6.26M | 0.01% | 1527 |
|
|
2013
Q3 | $8.63M | Sell |
192,929
-171,308
| -47% | -$7.59M | ﹤0.01% | 2048 |
|
|
2013
Q2 | $15.1M | Buy |
+364,237
| New | +$15.9M | 0.01% | 1381 |
|
Other funds holding ABBV
VCM
VPM
Susquehanna International Group's ABBV Position: Q1 2026 in Review
Susquehanna International Group increased its AbbVie (ABBV) stake by 51% in Q1 2026, buying an estimated $32.2M and bringing the position to 431,015 shares worth $93.7M. The position accounts for 0.01% of the portfolio, ranked #873.
Susquehanna International Group first reported a position in ABBV in Q2 2013 and has held it in 49 quarters since. The position peaked at $349M in Q4 2021. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Susquehanna International Group held 431,015 shares of AbbVie worth $93.7M as of Q1 2026.
- Susquehanna International Group bought 145,084 AbbVie shares in Q1 2026, an estimated $32.2M.
- AbbVie made up 0.01% of Susquehanna International Group's portfolio in Q1 2026, its #873 holding.
- Susquehanna International Group first reported a position in AbbVie in Q2 2013 and has held it in 49 quarters since.
- Susquehanna International Group's AbbVie position peaked at $349M in Q4 2021.
- 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.